Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

12. März 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1922


	Artikel 1 - 20 / 38432

	Integration of CT radiomics and machine learning for preoperative T staging of esophageal squamous cell carcinoma. J Thorac Dis Zhang X, Chen J, Wu W, Liu L, He P, Wu Y. PMID: 41816436 [PubMed]
	Gustave Roussy Immune Score as a prognostic marker in patients with esophageal cancer after neoadjuvant chemoradiotherapy: a retrospective study. J Thorac Dis Zhang L, Liang Z, Fang P, Zhou J, Yang Y, Luan S, Xiao X, Li X, Gu Y, Zhang H, Chen L, Zeng X, Yuan Y. PMID: 41816398 [PubMed]
	Fear of cancer recurrence in patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO-trial). Br J Surg Gangaram Panday SSG, SANO Study Group. PMID: 41814844 [PubMed - as supplied by publisher]
	Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma. Cancer Biol Ther Wang G, Li Z, Tan S, Ma J, Yin Z, Du J, Fan L. PMID: 41814475 [PubMed - indexed for MEDLINE]
	Length of stay affects long-term survival after esophageal cancer surgery: retrospective cohort study. J Cardiothorac Surg Dai YY, Yuan YP, Zheng YL, Wang FX. PMID: 41814340 [PubMed - as supplied by publisher]
	Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus. Dis Esophagus Provoost N, Zellenrath PA, Plompen EPC, Oudijk L, Koehler EM, Utomo W, van Tilburg AJP, Anten MP, Hazen WL, Akta, Koch AD, Honing J, Spaander MCW. PMID: 41812246 [PubMed - indexed for MEDLINE]
	Dosimetric comparison study of ultrahypofractionated photon versus proton treatment plans in post breast-conserving surgery breast cancer. PLoS One Saksornchai K, Tawonwong T, Oonsiri P, Vimolnoch M, Sarsitthithum T, Lertbutsayanukul C, Nantavithya C. PMID: 41811865 [PubMed - indexed for MEDLINE]
	Predictors of Post-Definitive Chemoradiotherapy Esophageal Stricture in T2-T4 Esophageal Squamous Cell Carcinoma: : A Single-Center Retrospective Study. J Gastrointest Cancer Ishida R, Nagata K, Horitani S, Futai R, Tokuyama N, Tobimatsu K, Kodama Y. PMID: 41811572 [PubMed - indexed for MEDLINE]
	Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer. Phys Imaging Radiat Oncol Ehmsen ML, Byskov CS, Mortensen HR, Bütof R, Canters R, Defraene G, Haustermans K, Jensen MF, Meijers A, Muijs CT, Møller DS, Nordsmark M, Populaire P, Vilches-Freixas G, Nyvang L, Stolarczyk L, Makocki S, Broggi S, Fracchiolla F, Martignano A, Poels K, Rossomme S, Vasiliniuc S, Hoffmann L. PMID: 41810037 [PubMed]
	High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer. World J Gastroenterol Zhang HM, Li FP, Zhang HY, Liu XR, Chen XH, Liang HY, Yan X, Xie Q, Zhong R, Lai M, Zhong XF, Liu H, Zhao LY. PMID: 41809879 [PubMed - indexed for MEDLINE]
	Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma. Cancer Kachnic LA, Moughan J, Hong TS, Haddock MG, Tahir N, Yoon HH, Diaz DA, Anderson CM, Seaward SA, Lominska CE, O'Brien PE, Chen Y, Salo JC, Christie AD, Dorth JA, Aljumaily RM, Gore EM, Winter KA, Safran HP, Movsas B. PMID: 41808581 [PubMed - indexed for MEDLINE]
	Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics. Nat Rev Clin Oncol Choo J, Sargsyan A, Khachatryan V, Lonardi S, Pietrantonio F, Sundar R, Klempner S, Janjigian Y. PMID: 41807638 [PubMed - as supplied by publisher]
	Current research status and challenges of neoadjuvant immunotherapy for Esophageal squamous cell carcinoma. Biochim Biophys Acta Rev Cancer Zhao W, Wang SQ, Lv H, Gao S, Chen XB. PMID: 41806941 [PubMed - as supplied by publisher]
	Health-related quality of life after definitive chemoradiotherapy in patients with esophageal carcinoma: a population-based analysis. Support Care Cancer Wekking D, Erdmann FH, Veen LM, Kuijper SC, Pape M, van Rossum PSN, Jeene PM, Neelis KJ, Slingerland M, Loosveld O, Rozema T, Sprangers MAG, Verhoeven RHA, van Laarhoven HWM. PMID: 41806066 [PubMed - indexed for MEDLINE]
	Endoscopic Innovation Treatment Strategy in Hepatocellular Carcinoma (HCC) Patients Before Immunotherapy: A Case Series Study in Unselected Patients. JGH Open Syofyan SD, Kovara K, Lesmana NP, Wiradikarta JN, Syofyan JF, Widjaja JB, Inggriani S, Hermawan R, Lesmana CRA. PMID: 41804306 [PubMed]
	Neoadjuvant camrelizumab combined with radiotherapy as a chemotherapy-sparing approach for resectable locally advanced esophageal squamous cell carcinoma: a phase II clinical trial (ESOCORT-NIRT). BMC Med Chen M, Huang Y, Zhang S, Chen C, Zeng T, Li H, Yang Z, Lin C, Li W, Xu B, Chen C, Zheng B. PMID: 41803866 [PubMed - as supplied by publisher]
	Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown. Nat Rev Clin Oncol Mannucci E, Dicembrini I. PMID: 41803464 [PubMed - as supplied by publisher]
	[Prevalence of Esophageal Squamous Cell Carcinoma among Patients with Head and Neck Cancer: A Single-Center Study]. Acta Gastroenterol Latinoam Martins Lima AV, Carvalho Franco F, Quevedo Penaloza CS, Cadena Aguirre D, Sartori Balbinot R, Rie Imada R, Marioni F, Nobre Moura R, Andrade de Paulo G, Vaz Safatle-Ribeiro A, Menezes da Cunha L, Gonçalves Ferreira F. PMID: 41800367 [PubMed]
	Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study. Front Pharmacol Jiang W, Peng W, Qian D, Wang G, Qian H, Deng W, Wang Z, Wei Z, Ma T, Zhao D, He Y, Li C, Wang G, Zheng Z, Guo X, Zhu S, Xia L, Jiang X, Wei J, Li X, Sun G. PMID: 41800100 [PubMed]
	Comparing artificial intelligence and multidisciplinary tumor board decision making in real-world cancer care: a prospective blinded concordance study. ESMO Real World Data Digit Oncol Pinninti R, Gullapalli R, Mallavarapu KM, Singareddy R, Nekkanti SS, Nikhil P, Shukla S, Hariharan N, Gudipudi D, Suseela K, Koppula V, Rao TS, Rajappa SJ. PMID: 41799836 [PubMed]

Artikel 1 - 20 / 38432

Seite 1 von 1922



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung